Effect of Magnesium Supplementation on Plasma C-reactive Protein Concentrations: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

@article{SimentalMenda2017EffectOM,
  title={Effect of Magnesium Supplementation on Plasma C-reactive Protein Concentrations: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.},
  author={Luis E. Simental-Mend{\'i}a and Amirhossein Sahebkar and Martha Rodr{\'i}guez-Moran and Graciela Zambrano-Galv{\'a}n and Fernando Guerrero‐Romero},
  journal={Current pharmaceutical design},
  year={2017},
  volume={23 31},
  pages={
          4678-4686
        }
}
BACKGROUND Results of previous clinical trials evaluating the effect of magnesium supplementation on inflammatory markers are controversial. OBJECTIVE A systematic review and meta-analysis of randomized controlled trials (RCTs) were performed to evaluating the effect of oral magnesium supplementation on plasma C-reactive protein (CRP) concentrations. METHOD PubMed-Medline, SCOPUS, Web of Science and Google Scholar databases were searched (from inception to August 09, 2016) to identify RCTs… 

The Effect of Oral Magnesium Supplementation on Inflammatory Biomarkers in Adults: A Comprehensive Systematic Review and Dose–response Meta-analysis of Randomized Clinical Trials

The notion that oral magnesium supplementation could have favorable effects on CRP, IL-6, and TNF-α in the adult population did not support the notion.

Effect of Magnesium Supplementation on Inflammatory Parameters: A Meta-Analysis of Randomized Controlled Trials

A systematic review and meta-analysis aimed to summarize the current state of the art of all randomized control trials (RCTs) investigating the effects of Mg supplementation versus placebo on serum parameters of inflammation and found that Mg supplemented levels may significantly reduce different human inflammatory markers.

Oral Magnesium Supplementation for the Prevention of Preeclampsia: a Meta-analysis or Randomized Controlled Trials

Oral supplementation of magnesium may reduce the risk of preeclampsia, which may be more remarkable in high-risk pregnant women.

The Effects of Magnesium and Vitamin E Co-Supplementation on Hormonal Status and Biomarkers of Inflammation and Oxidative Stress in Women with Polycystic Ovary Syndrome

Overall, magnesium and vitamin E co-supplementation for 12 weeks may benefit women with PCOS on hirsutism, serum hs-CRP, plasma NO, and TAC levels.

Effects of Melatonin and/or Magnesium Supplementation on Biomarkers of Inflammation and Oxidative Stress in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial

Overall, a favorable effect of co-supplementation of magnesium and melatonin for 8 weeks in women with PCOS on hirsutism, serum TNF-α, and TAC levels is found.

Magnesium-Zinc-Calcium-Vitamin D Co-supplementation Improves Hormonal Profiles, Biomarkers of Inflammation and Oxidative Stress in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial

Overall, magnesium-zinc-calcium-vitamin D co-supplementation for 12 weeks among PCOS women had beneficial effects on hormonal profiles, biomarkers of inflammation, and oxidative stress.

Clinical trial on the effects of oral magnesium supplementation in stable-phase COPD patients

The results suggests that oral magnesium supplementation may have a potential anti-inflammatory role, but does not seem to substantially influence lung function, physical performance, and quality of life in COPD patients.

The role of inflammation and the possibilities of inflammation reduction to prevent cardiovascular events

Overall, there is good data supporting associations between circulating hs-CRP and CV outcomes, however, the same was not seen in studies evaluating triggers of inflammation, such as oxidized LDL or Lp(a), and there is insufficient evidence showing treatments to target inflammation and lead to reductions in hs -CRP result in improvements in CV outcomes.
...